Influence of Testosterone on Dementia in Male Mice

About the Research Project
Program
Award Type
Postdoctoral Fellowship
Award Amount
$200,000
Active Dates
July 01, 2022 - June 30, 2025
Grant ID
A2022001F
Goals
I aim to study the effects of testosterone on cognition and pathology in a mouse model of multi etiology dementia.
Summary
Low testosterone levels in men are a risk factor for dementia and are associated with cognitive decline. This study will investigate the effects of testosterone removal and treatment on cognitive decline and pathology in a new mouse model of multi-etiology dementia. This addresses a major brain health issue in men (dementia) and contributes to the development of new treatments and preventions.
Unique and Innovative
This is the first study to utilize a second-generation knock-in mouse model of Alzheimer’s disease (AppNL-F mice) to create a multi-etiology dementia mouse model. Additionally, we will be the first to examine the role of androgens in any mouse model of multi-etiology dementia.
Foreseeable Benefits
This study examines the extent of androgens effects on cognition and pathology in a mouse model of Alzheimer’s disease and multi-etiology dementia. This is very important as 40 % of men over the age of 45 suffer from low androgen levels. However few studies have examined the role of androgens in Alzheimer’s disease, and none in multi-etiology dementia. This is a critical gap in knowledge because multi-etiology dementia accounts for up to 80% of all Alzheimer’s disease cases. Our study will provide mechanistic insight that will facilitate future interventions to decrease the burden of dementia.
Related Grants
Alzheimer's Disease Research
Interactions of Pregnancy and Menopause on Alzheimer’s Disease Outcomes
Active Dates
July 01, 2025 - June 30, 2028

Principal Investigator
Damian Zuloaga, PhD
Current Organization
University at Albany, SUNY
Alzheimer's Disease Research
Identifying Women-Specific and Men-Specific Risk Factors for Alzheimer’s Disease
Active Dates
July 01, 2022 - June 30, 2024

Principal Investigator
Gael Chetelat, PhD
Current Organization
University of Caen Normandy
Alzheimer's Disease Research
Developmental Determinants of Sexually Divergent Neuroinflammatory Processes
Active Dates
July 01, 2021 - June 30, 2024

Principal Investigator
Erin Reed-Geaghan, PhD
Current Organization
Northeast Ohio Medical University